Paul S. Changelian
Corporate Officer/Principal en Aclaris Life Sciences, Inc. .
Cargos activos de Paul S. Changelian
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Aclaris Life Sciences, Inc.
 Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Corporate Officer/Principal | - | - |
Historial de carrera de Paul S. Changelian
Antiguos cargos conocidos de Paul S. Changelian.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
| University of Michigan | Corporate Officer/Principal | 27/01/2010 | - |
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Lycera Corp.
 Lycera Corp. Pharmaceuticals: MajorHealth Technology Lycera Corp. develops novel oral medicines for treating autoimmune diseases and cancer. It specializes in immune metabolism, cell signaling and immune cell differentiation. The firm designed gut-directed ATPase modulator, designated LYC-30937, for the treatment of inflammatory bowel disease, and oral RORgamma agonists for diverse applications in immune-oncology. The company was founded in 2006 by Anthony William Opipari, Jr., and Gary D. Glick and is headquartered in Ann Arbor, MI. | Corporate Officer/Principal | 27/01/2010 | - |
Formación de Paul S. Changelian.
| University of Michigan | Undergraduate Degree |
| Harvard University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Corporate Officer/Principal | 5 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
| Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ACLARIS THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Lycera Corp.
Lycera Corp. Pharmaceuticals: MajorHealth Technology Lycera Corp. develops novel oral medicines for treating autoimmune diseases and cancer. It specializes in immune metabolism, cell signaling and immune cell differentiation. The firm designed gut-directed ATPase modulator, designated LYC-30937, for the treatment of inflammatory bowel disease, and oral RORgamma agonists for diverse applications in immune-oncology. The company was founded in 2006 by Anthony William Opipari, Jr., and Gary D. Glick and is headquartered in Ann Arbor, MI. | Health Technology |
Aclaris Life Sciences, Inc.
Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Health Services |
- Bolsa de valores
- Insiders
- Paul S. Changelian
- Experiencia
